219 related articles for article (PubMed ID: 30459436)
1. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival.
Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C
Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436
[TBL] [Abstract][Full Text] [Related]
2. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade.
Rambow F; Bechadergue A; Luciani F; Gros G; Domingues M; Bonaventure J; Meurice G; Marine JC; Larue L
J Invest Dermatol; 2016 Jun; 136(6):1229-1237. PubMed ID: 26968260
[TBL] [Abstract][Full Text] [Related]
4. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-125b in metastatic cutaneous malignant melanoma.
Glud M; Rossing M; Hother C; Holst L; Hastrup N; Nielsen FC; Gniadecki R; Drzewiecki KT
Melanoma Res; 2010 Dec; 20(6):479-84. PubMed ID: 20827223
[TBL] [Abstract][Full Text] [Related]
6. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ
Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
Xu Y; Brenn T; Brown ER; Doherty V; Melton DW
Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
[TBL] [Abstract][Full Text] [Related]
10. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
[TBL] [Abstract][Full Text] [Related]
11. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
13. Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T
Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-125b induces senescence in human melanoma cells.
Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
[TBL] [Abstract][Full Text] [Related]
16. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
18. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
Wang K; Zhang ZW
Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.
Zhang J; Na S; Liu C; Pan S; Cai J; Qiu J
Tumour Biol; 2016 May; 37(5):5941-9. PubMed ID: 26596831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
